Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 03-2013 | 12-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,769 | -11,887 | -12 | -15,042 | N/A |
| Depreciation Amortization | 917 | 623 | N/A | 628 | N/A |
| Accounts receivable | -1,000 | 239 | N/A | -397 | N/A |
| Accounts payable and accrued liabilities | -716 | -231 | N/A | 809 | N/A |
| Other Working Capital | 230 | 974 | 0 | 1,124 | N/A |
| Other Operating Activity | 19,331 | 1,219 | 0 | 215 | 0 |
| Operating Cash Flow | $-15,007 | $-9,063 | $-12 | $-12,663 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,487 | -379 | N/A | -830 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -35 | 0 |
| Investing Cash Flow | $-1,487 | $-379 | $N/A | $-865 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 6,929 | 6 | 6,811 | N/A |
| Debt Repayment | -2,596 | -1,829 | N/A | -610 | N/A |
| Common Stock Issued | 43,475 | -743 | 27 | 31 | N/A |
| Other Financing Activity | 0 | 4,152 | 0 | 8,476 | 0 |
| Financing Cash Flow | $40,879 | $8,509 | $33 | $14,708 | $N/A |
| Beginning Cash Position | 805 | 1,738 | 8 | 558 | N/A |
| End Cash Position | 25,190 | 805 | 29 | 1,738 | N/A |
| Net Cash Flow | $24,385 | $-933 | $21 | $1,180 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,007 | -9,063 | -12 | -12,663 | N/A |
| Capital Expenditure | -1,487 | -379 | N/A | -830 | N/A |
| Free Cash Flow | -16,494 | -9,442 | -12 | -13,493 | 0 |